{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:54:43Z","timestamp":1778777683272,"version":"3.51.4"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:p>\n                    Autoimmune liver diseases (AILDs), including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), often have complex interactions with thyroid diseases (TDs), such as hypothyroidism, hyperthyroidism, and Hashimoto thyroiditis (HT). These conditions frequently coexist and may share common autoimmune mechanisms, but their exact relationship remains poorly understood. Chronic hepatitis C (CHC), a viral liver disease, also affects thyroid function, but its interaction with TD is still under investigation. This study explores the causal links between AILD, CHC, and TD using data from the National Health and Nutrition Examination Survey (NHANES) and Mendelian randomization (MR) analysis. Data were sourced from NHANES (2013\u20132018) and various genome-wide association studies. The NHANES analysis included 8978 participants after applying inclusion and exclusion criteria. Logistic regression models were used to assess associations between CHC and TD. MR analysis employed single-nucleotide polymorphisms as instrumental variables to investigate causal relationships between AILD, CHC, and TD. NHANES analysis revealed no significant association between CHC and TD. Forward MR analysis indicated significant causal relationships between PBC and hypothyroidism (inverse variance weighting [IVW] odds ratio [OR]\u2005=\u20051.004, 95% confidence intervals [CI] 1.002\u20131.006,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), PSC and hyperthyroidism (IVW OR\u2005=\u20051.002, 95% CI 1.002\u20131.003,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and PBC and HT (IVW OR\u2005=\u20051.05, 95% CI 1.012\u20131.089,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.010). Reverse MR analysis suggested causal links between hypothyroidism, hyperthyroidism, HT, thyroid cancer, and AIH, as well as hypothyroidism with PBC and PSC. Multivariable MR confirmed significant associations between AIH and hypothyroidism (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), hyperthyroidism (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008) across IVW method. The IVW method also revealed another significant causal relationship between PSC and hyperthyroidism (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), HT (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.013). Multivariable MR also analysis to investigate the association between TD as exposures and AILD as outcomes; the IVW method revealed a noteworthy causal association solely between HT and AIH (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035). The study identified significant causal associations between AILD (particularly PBC and PSC) and specific TD, emphasizing the need for regular thyroid monitoring in AILD patients. However, no significant causal link was found between CHC and TD.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044112","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T19:02:21Z","timestamp":1756494141000},"page":"e44112","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies"],"prefix":"10.1097","volume":"104","author":[{"given":"Qilong","family":"Nie","sequence":"first","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwen","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Liang","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyang","family":"Li","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyang","family":"Huang","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"},{"name":"Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwei","family":"Yuan","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengyu","family":"Qiu","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"},{"name":"Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Ma","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"},{"name":"Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-9246","authenticated-orcid":false,"given":"Jianhong","family":"Li","sequence":"additional","affiliation":[{"name":"The Eighth Clinical Medical College, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China"},{"name":"Foshan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260406","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation.","volume":"60","author":"Carbone","year":"2014","journal-title":"J Hepatol"},{"key":"R2-20260406","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis.","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"R3-20260406","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population.","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20260406","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis.","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R5-20260406","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment.","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20260406","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","article-title":"Population-based epidemiology of primary biliary cirrhosis in South Korea.","volume":"43","author":"Kim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-20260406","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis.","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"R8-20260406","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5009\/gnl18085","article-title":"IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.","volume":"13","author":"Tanaka","year":"2019","journal-title":"Gut Liver"},{"key":"R9-20260406","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40618-020-01208-6","article-title":"The interplay between thyroid and liver: implications for clinical practice.","volume":"43","author":"Piantanida","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"R10-20260406","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2016.479","article-title":"Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European centers.","volume":"112","author":"Floreani","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R11-20260406","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1478-3231.2009.02003.x","article-title":"Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.","volume":"29","author":"Silveira","year":"2009","journal-title":"Liver Int"},{"key":"R12-20260406","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C.","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"key":"R14-20260406","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R15-20260406","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R16-20260406","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2468-1253(23)00018-3","article-title":"Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.","volume":"8","author":"Artenie","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R17-20260406","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00686.x","article-title":"Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.","volume":"50","author":"Huang","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R18-20260406","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","article-title":"Thyroid disorders in chronic hepatitis C.","volume":"117","author":"Antonelli","year":"2004","journal-title":"Am J Med"},{"key":"R19-20260406","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1001\/jama.281.17.1588","article-title":"Thyroid cancer in patients with hepatitis C infection.","volume":"281","author":"Antonelli","year":"1999","journal-title":"JAMA"},{"key":"R20-20260406","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/105072503322238809","article-title":"Interferon-alpha and autoimmune thyroid disease.","volume":"13","author":"Prummel","year":"2003","journal-title":"Thyroid"},{"key":"R21-20260406","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1440-1746.2009.05812.x","article-title":"Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?","volume":"24","author":"Vezali","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R22-20260406","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.jhep.2023.08.019","article-title":"Prevalence of steatotic liver disease and associated fibrosis in the United States: results from NHANES 2017-March 2020.","volume":"80","author":"Luo","year":"2024","journal-title":"J Hepatol"},{"key":"R23-20260406","doi-asserted-by":"crossref","first-page":"1120083","DOI":"10.3389\/fmed.2023.1120083","article-title":"Seropositive for hepatitis B and C viruses is associated with the risk of decreased bone mineral density in adults: an analysis of studies from the NHANES database.","volume":"10","author":"Tao","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R24-20260406","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016.","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"R25-20260406","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"key":"R26-20260406","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R27-20260406","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting.","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R28-20260406","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1891\/0730-0832.18.1.7","article-title":"Patterns of genetic inheritance.","volume":"18","author":"Reyna","year":"1999","journal-title":"Neonatal Netw"},{"key":"R29-20260406","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","article-title":"Mendelian randomization: new applications in the coming age of hypothesis-free causality.","volume":"16","author":"Evans","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"R30-20260406","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","article-title":"Statistical methods for Mendelian randomization in genome-wide association studies: a review.","volume":"20","author":"Boehm","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R31-20260406","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R32-20260406","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs.","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"key":"R33-20260406","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"R34-20260406","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R35-20260406","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R36-20260406","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/sim.6522","article-title":"Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome.","volume":"34","author":"Greco M","year":"2015","journal-title":"Stat Med"},{"key":"R37-20260406","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1373\/clinchem.2009.141564","article-title":"Mendelian randomization in the era of genomewide association studies.","volume":"56","author":"Sleiman","year":"2010","journal-title":"Clin Chem"},{"key":"R38-20260406","first-page":"788","article-title":"Autoimmune thyroid disease: further developments in our understanding.","volume":"15","author":"Weetman","year":"1994","journal-title":"Endocr Rev"},{"key":"R39-20260406","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/08916934.2016.1261835","article-title":"Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.","volume":"50","author":"Inoue","year":"2017","journal-title":"Autoimmunity"},{"key":"R40-20260406","first-page":"42","article-title":"Investigation on the prevalence of autoimmune thyroid diseases in patients with autoimmune hepatitis and primary biliary cirrhosis.","volume":"25","author":"Yan","year":"2022","journal-title":"J Pract Liver Dis"},{"key":"R41-20260406","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis.","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R42-20260406","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00365521.2019.1710766","article-title":"Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study.","volume":"55","author":"Zeng","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"R43-20260406","first-page":"100","article-title":"Thyroid dysfunction is prevalent in autoimmune hepatitis: a case control study.","volume":"22","author":"Khoury","year":"2020","journal-title":"Isr Med Assoc J"},{"key":"R44-20260406","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/1050725041692927","article-title":"Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto\u2019s thyroiditis: case report.","volume":"14","author":"Salvi","year":"2004","journal-title":"Thyroid"},{"key":"R45-20260406","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2169\/internalmedicine.52.6799","article-title":"Hashimoto\u2019s thyroiditis concomitant with sequential autoimmune hepatitis, chorea and polyserositis: a new entity of autoimmune polyendocrine syndrome?","volume":"52","author":"Yu","year":"2013","journal-title":"Intern Med"},{"key":"R46-20260406","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/medicina45070076","article-title":"[Risk factors and pathogenesis of Hashimoto\u2019s thyroiditis].","volume":"45","author":"Paknys","year":"2009","journal-title":"Medicina (Kaunas)"},{"key":"R47-20260406","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome.","volume":"36","author":"Efe","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R48-20260406","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/hepr.13910","article-title":"Characteristic geoepidemiology of primary biliary cholangitis in Taiwan: a nationwide population-based study.","volume":"53","author":"Cheng","year":"2023","journal-title":"Hepatol Res"},{"key":"R49-20260406","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism.","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R50-20260406","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.31296","article-title":"Thyroid hormone signaling and the liver.","volume":"72","author":"Ritter","year":"2020","journal-title":"Hepatology"},{"key":"R51-20260406","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ajpath.2018.03.008","article-title":"Understanding liver regeneration: from mechanisms to regenerative medicine.","volume":"188","author":"Gilgenkrantz","year":"2018","journal-title":"Am J Pathol"},{"key":"R52-20260406","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI29812","article-title":"Deiodinases: implications of the local control of thyroid hormone action.","volume":"116","author":"Bianco","year":"2006","journal-title":"J Clin Invest"},{"key":"R53-20260406","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11883-016-0564-7","article-title":"Thyroid hormone mimetics: the past, current status and future challenges.","volume":"18","author":"Elbers","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"R54-20260406","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fendo.2013.00115","article-title":"Type 3 deiodinase and consumptive hypothyroidism: a common mechanism for a rare disease.","volume":"4","author":"Luongo","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R55-20260406","doi-asserted-by":"crossref","first-page":"984697","DOI":"10.3389\/fimmu.2022.984697","article-title":"Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis.","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"R56-20260406","doi-asserted-by":"crossref","first-page":"e34442","DOI":"10.1371\/journal.pone.0034442","article-title":"Novel associations for hypothyroidism include known autoimmune risk loci.","volume":"7","author":"Eriksson","year":"2012","journal-title":"PLoS One"},{"key":"R57-20260406","first-page":"441","article-title":"HLA Class II allele groups involved in autoimmune thyroid diseases: Hashimoto\u2019s thyroiditis and Basedow-Graves disease.","volume":"14","author":"Chiorean","year":"2024","journal-title":"Life (Basel)"},{"key":"R58-20260406","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.1984.03350170010007","article-title":"Hypothyroidism-associated cholestasis.","volume":"252","author":"Ariza","year":"1984","journal-title":"JAMA"},{"key":"R59-20260406","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1172\/JCI106721","article-title":"Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasis.","volume":"50","author":"Reyes","year":"1971","journal-title":"J Clin Invest"},{"key":"R60-20260406","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1172\/JCI106182","article-title":"Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.","volume":"48","author":"Levi","year":"1969","journal-title":"J Clin Invest"},{"key":"R61-20260406","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3389\/fimmu.2019.02633","article-title":"Constitutive activation of natural killer cells in primary biliary cholangitis.","volume":"10","author":"Hydes","year":"2019","journal-title":"Front Immunol"},{"key":"R62-20260406","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/er.2013-1087","article-title":"Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.","volume":"35","author":"Fekete","year":"2014","journal-title":"Endocr Rev"},{"key":"R63-20260406","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis.","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"R64-20260406","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12016-010-8221-3","article-title":"Cutting edge issues in primary sclerosing cholangitis.","volume":"41","author":"Bowlus","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"R65-20260406","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2015.03.021","article-title":"Genetic distinctions in patients with primary sclerosing cholangitis: immunoglobulin G4 elevations and HLA Risk.","volume":"148","author":"Liaskou","year":"2015","journal-title":"Gastroenterology"},{"key":"R66-20260406","doi-asserted-by":"crossref","first-page":"389537","DOI":"10.1155\/2013\/389537","article-title":"Role of the microbiota and antibiotics in primary sclerosing cholangitis.","volume":"2013","author":"Tabibian","year":"2013","journal-title":"Biomed Res Int"},{"key":"R67-20260406","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1053\/j.gastro.2019.10.012","article-title":"A mechanistic insight into the role of gut microbiota in the pathogenesis of primary sclerosing cholangitis.","volume":"157","author":"Patel","year":"2019","journal-title":"Gastroenterology"},{"key":"R68-20260406","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/1871530319666190930110605","article-title":"Our little friends with big roles: alterations of the gut microbiota in thyroid disorders.","volume":"20","author":"Ejtahed","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R69-20260406","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/nu12061769","article-title":"Thyroid-gut-axis: how does the microbiota influence thyroid function?","volume":"12","author":"Knezevic","year":"2020","journal-title":"Nutrients"},{"key":"R70-20260406","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"R71-20260406","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apt.15375","article-title":"Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.","volume":"50","author":"R\u00fchlemann","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R72-20260406","doi-asserted-by":"crossref","first-page":"227","DOI":"10.15403\/jgld.2014.1121.252.chc","article-title":"Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis.","volume":"25","author":"Shen","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"R73-20260406","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4158\/EP12195.RA","article-title":"Thyroid disease in chronic hepatitis C infection treated with combination interferon-\u03b1 and ribavirin: management strategies and future perspective.","volume":"19","author":"Tran","year":"2013","journal-title":"Endocr Pract"},{"key":"R74-20260406","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40618-022-01909-0","article-title":"Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity.","volume":"46","author":"Rodia","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"R75-20260406","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2893.2005.00699.x","article-title":"Is hepatitis C virus a risk factor for thyroid autoimmunity?","volume":"13","author":"Floreani","year":"2006","journal-title":"J Viral Hepat"},{"key":"R76-20260406","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0168-8278(95)80291-6","article-title":"Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction.","volume":"22","author":"Marcellin","year":"1995","journal-title":"J Hepatol"},{"key":"R77-20260406","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/jir.2016.0007","article-title":"Thyroid dysfunction in chronic hepatitis C patients treated with the combined pegylated interferon-ribavirin therapy.","volume":"36","author":"Hamza","year":"2016","journal-title":"J Interferon Cytokine Res"},{"key":"R78-20260406","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3904\/kjim.2015.30.6.792","article-title":"Incidence of and risk factors for thyroid dysfunction during peginterferon \u03b1 and ribavirin treatment in patients with chronic hepatitis C.","volume":"30","author":"Hwang","year":"2015","journal-title":"Korean J Intern Med"},{"key":"R79-20260406","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12902-019-0362-7","article-title":"Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.","volume":"19","author":"Chang","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"R80-20260406","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2265.2010.03785.x","article-title":"Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy.","volume":"73","author":"Costelloe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:02:11Z","timestamp":1775455331000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":79,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044112","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"2024-10-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}